Literature DB >> 28352916

A threonine turnstile defines a dynamic amphiphilic binding motif in the AAA ATPase p97 allosteric binding site.

James C Burnett1, Chaemin Lim, Brian D Peyser, Lalith P Samankumara, Marina Kovaliov, Raffaele Colombo, Stacie L Bulfer, Matthew G LaPorte, Ann R Hermone, Connor F McGrath, Michelle R Arkin, Rick Gussio, Donna M Huryn, Peter Wipf.   

Abstract

The turnstile motion of two neighboring threonines sets up a dynamic side chain interplay that can accommodate both polar and apolar ligands in a small molecule allosteric protein binding site. A computational model based on SAR data and both X-ray and cryo-EM structures of the AAA ATPase p97 was used to analyze the effects of paired threonines at the inhibitor site. Specifically, the Thr side chain hydroxyl groups form a hydrogen bonding network that readily accommodates small, highly polar ligand substituents. Conversely, diametric rotation of the χ1 torsion by 150-180° orients the side chain β-methyl groups into the binding cleft, creating a hydrophobic pocket that can accommodate small, apolar substituents. This motif was found to be critical for rationalizing the affinities of a structurally focused set of inhibitors of p97 covering a > 2000-fold variation in potencies, with a preference for either small-highly polar or small-apolar groups. The threonine turnstile motif was further validated by a PDB search that identified analogous binding modes in ligand interactions in PKB, as well as by an analysis of NMR structures demonstrating additional gear-like interactions between adjacent Thr pairs. Combined, these data suggest that the threonine turnstile motif may be a general feature of interest in protein binding pockets.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28352916      PMCID: PMC5472064          DOI: 10.1039/c7ob00526a

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  24 in total

1.  Interprotomer motion-transmission mechanism for the hexameric AAA ATPase p97.

Authors:  Guangtao Li; Chengdong Huang; Gang Zhao; William J Lennarz
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-21       Impact factor: 11.205

2.  Identification of 4-(4-aminopiperidin-1-yl)-7H-pyrrolo[2,3-d]pyrimidines as selective inhibitors of protein kinase B through fragment elaboration.

Authors:  John J Caldwell; Thomas G Davies; Alastair Donald; Tatiana McHardy; Martin G Rowlands; G Wynne Aherne; Lisa K Hunter; Kevin Taylor; Ruth Ruddle; Florence I Raynaud; Marcel Verdonk; Paul Workman; Michelle D Garrett; Ian Collins
Journal:  J Med Chem       Date:  2008-03-18       Impact factor: 7.446

3.  Improved structures of full-length p97, an AAA ATPase: implications for mechanisms of nucleotide-dependent conformational change.

Authors:  Jason M Davies; Axel T Brunger; William I Weis
Journal:  Structure       Date:  2008-05       Impact factor: 5.006

4.  Platinum-catalyzed C-H arylation of simple arenes.

Authors:  Anna M Wagner; Amanda J Hickman; Melanie S Sanford
Journal:  J Am Chem Soc       Date:  2013-10-15       Impact factor: 15.419

5.  2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.

Authors:  I Tapia; L Alonso-Cires; P L López-Tudanca; R Mosquera; L Labeaga; A Innerárity; A Orjales
Journal:  J Med Chem       Date:  1999-07-29       Impact factor: 7.446

6.  Discovery of 4-amino-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamides as selective, orally active inhibitors of protein kinase B (Akt).

Authors:  Tatiana McHardy; John J Caldwell; Kwai-Ming Cheung; Lisa J Hunter; Kevin Taylor; Martin Rowlands; Ruth Ruddle; Alan Henley; Alexis de Haven Brandon; Melanie Valenti; Thomas G Davies; Lynsey Fazal; Lisa Seavers; Florence I Raynaud; Suzanne A Eccles; G Wynne Aherne; Michelle D Garrett; Ian Collins
Journal:  J Med Chem       Date:  2010-03-11       Impact factor: 7.446

7.  Discovery of a First-in-Class, Potent, Selective, and Orally Bioavailable Inhibitor of the p97 AAA ATPase (CB-5083).

Authors:  Han-Jie Zhou; Jinhai Wang; Bing Yao; Steve Wong; Stevan Djakovic; Brajesh Kumar; Julie Rice; Eduardo Valle; Ferdie Soriano; Mary-Kamala Menon; Antonett Madriaga; Szerenke Kiss von Soly; Abhinav Kumar; Francesco Parlati; F Michael Yakes; Laura Shawver; Ronan Le Moigne; Daniel J Anderson; Mark Rolfe; David Wustrow
Journal:  J Med Chem       Date:  2015-12-04       Impact factor: 7.446

8.  Di-substituted pyridinyl aminohydantoins as potent and highly selective human beta-secretase (BACE1) inhibitors.

Authors:  Michael S Malamas; Keith Barnes; Matthew Johnson; Yu Hui; Ping Zhou; Jim Turner; Yun Hu; Erik Wagner; Kristi Fan; Rajiv Chopra; Andrea Olland; Jonathan Bard; Menelas Pangalos; Peter Reinhart; Albert J Robichaud
Journal:  Bioorg Med Chem       Date:  2009-12-06       Impact factor: 3.641

9.  Selective inhibition of p97 by chlorinated analogues of dehydrocurvularin.

Authors:  Joseph Tillotson; Bharat P Bashyal; MinJin Kang; Taoda Shi; Fabian De La Cruz; A A Leslie Gunatilaka; Eli Chapman
Journal:  Org Biomol Chem       Date:  2016-05-25       Impact factor: 3.876

10.  2.3 Å resolution cryo-EM structure of human p97 and mechanism of allosteric inhibition.

Authors:  Soojay Banerjee; Alberto Bartesaghi; Alan Merk; Prashant Rao; Stacie L Bulfer; Yongzhao Yan; Neal Green; Barbara Mroczkowski; R Jeffrey Neitz; Peter Wipf; Veronica Falconieri; Raymond J Deshaies; Jacqueline L S Milne; Donna Huryn; Michelle Arkin; Sriram Subramaniam
Journal:  Science       Date:  2016-01-28       Impact factor: 47.728

View more
  4 in total

1.  Modified carbazoles destabilize microtubules and kill glioblastoma multiform cells.

Authors:  Philippe Diaz; Eric Horne; Cong Xu; Ernest Hamel; Michael Wagenbach; Ravil R Petrov; Benjamin Uhlenbruck; Brian Haas; Parvinder Hothi; Linda Wordeman; Rick Gussio; Nephi Stella
Journal:  Eur J Med Chem       Date:  2018-09-11       Impact factor: 6.514

2.  Targeting ovarian cancer and endothelium with an allosteric PTP4A3 phosphatase inhibitor.

Authors:  Kelley E McQueeney; Joseph M Salamoun; James C Burnett; Nektarios Barabutis; Paula Pekic; Sophie L Lewandowski; Danielle C Llaneza; Robert Cornelison; Yunpeng Bai; Zhong-Yin Zhang; John D Catravas; Charles N Landen; Peter Wipf; John S Lazo; Elizabeth R Sharlow
Journal:  Oncotarget       Date:  2017-12-30

3.  Optimization of Phenyl Indole Inhibitors of the AAA+ ATPase p97.

Authors:  Matthew G LaPorte; James C Burnett; Raffaele Colombo; Stacie L Bulfer; Celeste Alverez; Tsui-Fen Chou; R Jeffrey Neitz; Neal Green; William J Moore; Zhizhou Yue; Shan Li; Michelle R Arkin; Peter Wipf; Donna M Huryn
Journal:  ACS Med Chem Lett       Date:  2018-09-18       Impact factor: 4.345

4.  The p97 Inhibitor UPCDC-30245 Blocks Endo-Lysosomal Degradation.

Authors:  Feng Wang; Shan Li; Kai-Wen Cheng; William M Rosencrans; Tsui-Fen Chou
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.